2015
DOI: 10.1016/j.tube.2014.11.002
|View full text |Cite
|
Sign up to set email alerts
|

HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model – A potential novel therapeutic target

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 24 publications
0
13
0
Order By: Relevance
“…Deletion or chemical inhibition in vitro of HspX in M. tuberculosis decreased viability in hypoxia 36,38 . When mice were infected by an HspX-deficient strain of M. tuberculosis , the strain grew to a greater organ burden compared with the wild-type parent strain, but was more rapidly cleared upon antibiotic treatment, suggesting that HspX played potentially opposing roles in fitness to the host versus antibiotics in that model 39 . By sorting insoluble protein aggregates to a distinct cellular location, HspX acts to compartmentalize the cell in the absence of membrane-bound organelles.…”
Section: Discussionmentioning
confidence: 99%
“…Deletion or chemical inhibition in vitro of HspX in M. tuberculosis decreased viability in hypoxia 36,38 . When mice were infected by an HspX-deficient strain of M. tuberculosis , the strain grew to a greater organ burden compared with the wild-type parent strain, but was more rapidly cleared upon antibiotic treatment, suggesting that HspX played potentially opposing roles in fitness to the host versus antibiotics in that model 39 . By sorting insoluble protein aggregates to a distinct cellular location, HspX acts to compartmentalize the cell in the absence of membrane-bound organelles.…”
Section: Discussionmentioning
confidence: 99%
“…It is characterized by the inoculation of a large number of bacteria intravenously to initiate an infection and the treatment of the disease once the infection has been established (2 to 3 weeks postinfection). In this model, an intensive treatment is able to render mouse organs culture negative on agar plates and in broth culture lacking culture filtrate, but it fails to prevent relapse ( 10 , 11 ). However, these apparently culture-negative organs contained viable bacteria that could be cultivated by supplementing broth media with culture filtrate ( 6 ) containing RPF ( 7 ).…”
Section: Discussionmentioning
confidence: 99%
“…Female BALB/c mice (6 to 8 weeks old) were obtained from Harlan United Kingdom Ltd. A total of 364 mice were infected intravenously via the tail vein with 1.2 × 10 5 CFU of mouse-passaged M. tuberculosis strain H37Rv per mouse as described previously ( 8 , 10 , 11 ). The animal husbandry guidelines and all animal experiments were performed according to the Animals Scientific Procedures Act, 1986 (an Act of the Parliament of the United Kingdom 1986 c. 14) (Home Office Project license Number 70/7077) with approval from the St. George's, University of London, ethics committee.…”
Section: Methodsmentioning
confidence: 99%
“…In developing countries implementation of MDR-TB control programmeis challenging. Hence, novel therapeutic targets, especially those associated with M. tuberculosis dormancy that can potentially shorten the duration of chemotherapy and reduce relapse rates would be of great value [21]. …”
Section: Latent Tuberculosismentioning
confidence: 99%